Favet Michael 4
4 · NeuroPace Inc · Filed Apr 26, 2021
Insider Transaction Report
Form 4
NeuroPace IncNPCE
Favet Michael
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2021-04-26$0.03/sh+15,385$462→ 22,947 total(indirect: See Footnote) - Conversion
Series A' Preferred Stock
2021-04-26−343→ 0 total(indirect: See Footnote)Exercise: $0.00→ Common Stock (343 underlying) - Conversion
Series B' Preferred Stock
2021-04-26−7,219→ 0 total(indirect: See Footnote)Exercise: $0.00→ Common Stock (7,219 underlying) - Conversion
Common Stock
2021-04-26+7,562→ 7,562 total(indirect: See Footnote)
Footnotes (2)
- [F1]Shares are held by the Favet Living Trust, of which the Reporting Person and the Reporting Person's spouse serve as co-trustees.
- [F2]Each share of Preferred Stock automatically converted on a 1-for-1 basis into Common Stock at any time upon the closing of the Issuer's initial public offering, for no additional consideration. The Preferred Stock has no expiration date.